Scientists need to perform intensive research and study to design a vaccine against particular microbes. This vaccine is based on the fundamental information such as how it infects the human or animal cell and what is the immune reaction of the infected cell. Researchers have developed different types of vaccines such as live attenuated vaccines, subunit vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, DNA vaccines, and recombinant vector vaccines.
In recent years, the recombinant DNA technology has been used to generate new vaccines. This technology has helped scientists to develop recombinant vector vaccines against various bacterial and viral diseases. Recombinant vector vaccines are similar to DNA vaccines; however, these consist of an attenuated viral particle or bacterium as a vector.
Viruses adsorb on to a cell and inject their genetic material into them. Scientists have taken advantage of this viral nature and developed recombinant viral vector vaccines using attenuated virus as a carrier of the genetic material into the host cell. Recombinant vector vaccines have several advantages over other traditional vaccines. These vaccines closely mimic a natural infection caused by a particular microbe, thereby generating a good immune response against it. Recombinant vector vaccine strategy enables triggering of T- lymphocyte, and antigens, are thus presented to T- cell lymphocytes which generates a strong cell mediated immune response in the body against that particular antigen or microbe. Moreover, it reduces need of repeat dosage to treat a particular disease. Attenuated bacterium can also be used as an efficient vector to generate recombinant vector vaccines. In this case, genetic material is inserted into the bacterial vector, causing the bacteria to express the antigens of other microorganism onto its surface, generating an immune response. Strong research is being carried out to develop recombinant vector vaccines for rabies, HIV, and measles. Currently, adenovirus vectors, poxvirus vectors, and alphavirus vectors are extensively studied and used to prepare vaccines.
Rapid development in molecular biology and genetic engineering is the key driver of the global recombinant vector vaccine market. The market is expected to show a rapid growth during the forecast period. However, substantial number of pharmaceutical challenges associated with the development of recombinant vector vaccines and stringent regulatory norms laid by the regulatory bodies is likely to restrain the market.
The global recombinant vector vaccines market can be segmented based on type of vector, disease type, and region. In terms of type of vector, the market can be bifurcated into recombinant viral vector vaccines and recombinant bacterial vector vaccines. The recombinant viral vector vaccines segment holds the maximum share of the market. Based on disease type, the market can be segmented into vector vaccines used to treat various viral and bacterial infections. Recombinant vector vaccines are being developed to treat cancer.
Geographically, the global recombinant vector vaccines market can be segmented into Europe, Asia Pacific, Latin America, North America, and Middle East & Africa. North America held a major share in 2016, owing to rise in technology advancements in molecular biology and genetic engineering. Increasing awareness, government initiatives, and availability of vector vaccines are expected to boost the growth of the market in Asia Pacific. The recombinant vector vaccines market in Europe is anticipated to grow during the forecast period owing to technological developments and increasing prevalence of infectious diseases.
Key players in the global recombinant vector vaccines market include Sanofi, Pfizer, Inc., Novartis AG, Neuron Biotech, Merck and Company, GlaxoSmithKline plc, CSL Limited, Biological E, and Bharat Biotech.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.